1. Alwan, N.A.S., F.H. Mualla, M. Al Naqash, S. Kathum, F.N. Tawfiq and S. Nadhir, 2017. Clinical and pathological characteristics of triple positive breast cancer among Iraqi patients. Gulf J. Oncol., 1: 51-60.
   PubMed  |  
2. Al-Rawi, S., B.O. Saleh and M. Al-Naqqash, 2017. The role of serum follicle stimulating hormone in prognosis of chemotherapy effect on ovarian reserve in Iraqi breast cancer women. IOSR J. Pharm. Biol. Sci., 12: 7-9.
3. Mohammed, M.B., B.A. Razzaq, M.A.E. Al-Naqqash and S.Y. Jasim, 2016. Effects of cranberry-PACs against urinary problems associated with radiotherapy in Iraqi patients with bladder carcinoma. Int. J. Pharm. Sci. Rev. Res., 39: 179-188.
4. Al-Rawaq, K.J., M.A. Al-Naqqash and M.K. Jassim, 2016. Molecular classification of Iraqi breast cancer patients and its correlation with patients’ profile. J. Fac. Med. Bagdad, 58: 197-201.
   CrossRef  |  Direct Link  |  
5. Al-Rawi, Z.S., F.I. Gorial and M.A. Alnaqqash, 2015. Prevalence and predictors of low bone mineral density in Iraqi patients with breast cancer: A cross sectional study. IOSR J. Dent. Med. Sci., 14: 61-66.
   Direct Link  |  
6. Abdullah, A.H., K.M. Turki and M.A. Al Naqqash, 2013. Insulin like growth factor and risk of breast cancer. IOSR J. Applied Chem., 5: 59-62.
   Direct Link  |  
7. Mshemish, B.A.R., K.A. Al-Khazragy, M.A.I. Al-Nakaash and W.A. Fatah, 2011. Effect of silymarin against CAF protocol hepatotoxicity. Al-Mustansiriyah J. Pharm. Sci., 9: 52-62.